anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Fusion Pharmaceuticals · pitchdeck

Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides

30 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides

Fusion Pharmaceuticals · 2023-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 11 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 3 slides 100% 3/3 slides 100% 3/3 slides · 13 hits
— 0/3 slides
66.7% 2/3 slides · 3 hits 66.7% 2/3 slides 100% 3/3 slides 100% 3/3 slides Solution 4 slides 100% 4/4 slides 100% 4/4 slides · 30 hits
— 0/4 slides
50% 2/4 slides
— 0/4 slides
100% 4/4 slides · 5 hits 100% 4/4 slides Market Opportunity 3 slides 100% 3/3 slides 100% 3/3 slides · 15 hits
— 0/3 slides
— 0/3 slides
33.3% 1/3 slides 100% 3/3 slides
— 0/3 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 11 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides · 2 hits 100% 1/1 slides

Slide inventory

30
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a combination of bulleted benefits and a visual process diagram to explain the mechanism of action.argue_timing
Open slide detailBeat · ProblemLoop · Why Now
04
The slide uses a linear process flow to highlight competitive differentiation.present_framework
Open slide detailBeat · ProblemLoop · Why Now
05
The slide uses a Gantt-style visualization to represent drug development stages.plan_implementation
Open slide detailBeat · ProblemLoop · Why Now
06
The slide emphasizes vertical integration and strategic supply agreements as a moat.present_solution
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
07
Includes a logo grid of previous affiliations at the bottom.summarize
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
08
transition
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
09
Includes a visual case study (Subject #4) showing PET scan response.show_traction
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
10
Includes a clinical case study image showing patient response to therapy.plan_implementation
Open slide detailBeat · Market Opportunity
11
The slide illustrates the transition from a 177Lu-based molecule (IPN-1087) to a 225Ac-based molecule (FPI-2059) to improve efficacy.present_solution
Open slide detailBeat · Market Opportunity
12
The slide outlines a standard clinical trial dose escalation design (3+3) for a radiopharmaceutical.plan_implementation
Open slide detailBeat · Market Opportunity
13
transition
Open slide detail
14
The slide contrasts a chemotherapy-based approach (SMDC) with a radioligand therapy (RLT) approach, highlighting the superior PSA response in the RLT cohort.compare_peers
Open slide detail
15
The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify market opportunity by tumor type.present_solution
Open slide detail
16
The slide uses a process flow diagram to map out different study arms and their respective patient cohorts.plan_implementation
Open slide detail
17
The chart shows FPI-1434 Plasma AUC for two different dosing regimens.analyze_data
Open slide detail
18
The slide highlights a specific program (Program 1) involving dual targeting of EGFR and cMET using Fusion's FastClear linker technology.present_solution
Open slide detail
19
The slide uses a combination of a process diagram for the in vivo study and a line chart to show efficacy results.present_solution
Open slide detail
20
transition
Open slide detail
21
The slide combines financial status with a timeline of clinical milestones.show_traction
Open slide detail
22
state_next_steps
Open slide detail
23
appendix
Open slide detail
24
The slide uses medical imaging (SPECT/CT) to visually demonstrate the efficacy of a pre-dose strategy in optimizing pharmacokinetics.present_solution
Open slide detail
25
The slide presents clinical trial data comparing pharmacokinetics and safety (thrombocytopenia) profiles.analyze_data
Open slide detail
26
Includes specific highlighting boxes (green, yellow, red) around data subsets.analyze_data
Open slide detail
27
Includes SPECT/CT imaging evidence and dosimetric data tables.analyze_data
Open slide detail
28
Includes a PET/CT scan image as a case study example.show_traction
Open slide detail
29
The slide uses a spectrum chart to show increasing potency of toxins and a table to list advantages of TATs over ADCs.present_solution
Open slide detail
30
The slide uses a process diagram to show the excretion pathway and a line chart to demonstrate the 3.1x improvement in excretion rate compared to a commercial lpresent_solution
Open slide detail